Track the CITIUS ONCOLOGY, INC. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €68.6m. The latest transaction was disclosed on 22 December 2025 (Attribution). Among the most active insiders: HOLUBIAK MYRON Z. Every trade is accessible without an account.
32
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CITIUS ONCOLOGY, INC. Buy (bullish), based on 1 analysts. Average price target: US$4.00.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CITIUS ONCOLOGY, INC. es una empresa dedicada al desarrollo de tratamientos innovadores contra el cáncer. Su objetivo es mejorar los resultados para pacientes con enfermedades oncológicas.